NR1I2 and neoplasm: Immunohistochemistry (IHC) staining results suggested that tumor cell proliferation was inhibited (Ki67), cell apoptosis (cleaved caspase 3) increased, and P-gp, PXR, and Tip60 expression remarkably reduced in the combination treatment group.